Memory T cells include T memory stem cells (TSCM) and central memory T cells (TCM).
Compared with effector memory T cells (TEM) and effector T cells (TEFF), they have better …

Simple Summary Immunotherapies have revolutionized the management of advanced stage
cancer; however, not all patients benefit given many cancers are resistant to immune …

Introduction Triple-negative breast cancer (TNBC) is a highly aggressive subtype with a poor
prognosis. Current single-agent checkpoint therapy has limited effectiveness in TNBC …

Over the last two decades, a large volume of studies has established that dying and dead
cancer cells exert a potent immunomodulatory effect on their immediate microenvironment …

While chemotherapeutic agents were long solely associated with immunosuppression,
clinical data demonstrate that the combination of some chemotherapies with …

CD4 T cell effector subsets not only profoundly affect cancer progression, but recent
evidence also underscores their critical contribution to the anticancer efficacy of immune …

Résumé Les succès obtenus dans le domaine de l'immunothérapie anticancéreuse grâce
aux inhibiteurs des points de contrôle immunitaire montrent que la capacité des cellules du …